{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:15:59Z","timestamp":1793330159198,"version":"4.5.0"},"reference-count":48,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The John and Marilyn Bishop Charitable Foundation"},{"name":"Fred A. &amp; Barbara M. Erb Foundation &amp; Maibach family"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Precision neurology combines high-throughput technologies and statistical modeling to identify novel disease pathways and predictive biomarkers in Alzheimer\u2019s disease (AD). Brain cytochrome P450 (CYP) genes are major regulators of cholesterol, sex hormone, and xenobiotic metabolism, and they could play important roles in neurodegenerative disorders. Increasing evidence suggests that epigenetic factors contribute to AD development. We evaluated cytosine (\u2018CpG\u2019)-based DNA methylation changes in AD using circulating cell-free DNA (cfDNA), to which neuronal cells are known to contribute. We investigated CYP-based mechanisms for AD pathogenesis and epigenetic biomarkers for disease detection. We performed a case\u2013control study using 25 patients with AD and 23 cognitively healthy controls using the cfDNA of CYP genes. We performed a logistic regression analysis using the MetaboAnalyst software computer program and a molecular pathway analysis based on epigenetically altered CYP genes using the Cytoscape program. We identified 130 significantly (false discovery rate correction q-value &lt; 0.05) differentially methylated CpG sites within the CYP genes. The top two differentially methylated genes identified were CYP51A1 and CYP2S1. The significant molecular pathways that were perturbed in AD cfDNA were (i) androgen and estrogen biosynthesis and metabolism, (ii) C21 steroid hormone biosynthesis and metabolism, and (iii) arachidonic acid metabolism. Existing evidence suggests a potential role of each of these biochemical pathways in AD pathogenesis. Next, we randomly divided the study group into discovery and validation sub-sets, each consisting of patients with AD and control patients. Regression models for AD prediction based on CYP CpG methylation markers were developed in the discovery or training group and tested in the independent validation group. The CYP biomarkers achieved a high predictive accuracy. After a 10-fold cross-validation, the combination of cg17852385\/cg23101118 + cg14355428\/cg22536554 achieved an AUC (95% CI) of 0.928 (0.787~1.00), with 100% sensitivity and 92.3% specificity for AD detection in the discovery group. The performance remained high in the independent validation or test group, achieving an AUC (95% CI) of 0.942 (0.905~0.979) with a 90% sensitivity and specificity. Our findings suggest that the epigenetic modification of CYP genes may play an important role in AD pathogenesis and that circulating CYP-based cfDNA biomarkers have the potential to accurately and non-invasively detect AD.<\/jats:p>","DOI":"10.3390\/ijms24032876","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T03:24:49Z","timestamp":1675308289000},"page":"2876","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Alzheimer\u2019s Precision Neurology: Epigenetics of Cytochrome P450 Genes in Circulating Cell-Free DNA for Disease Prediction and Mechanism"],"prefix":"10.3390","volume":"24","author":[{"given":"Ray O.","family":"Bahado-Singh","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oakland University-William Beaumont School of Medicine, Royal Oak, MI 48309, USA"},{"name":"Corewell Health William Beaumont University Hospital, Royal Oak, MI 48073, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5681-5143","authenticated-orcid":false,"given":"Sangeetha","family":"Vishweswaraiah","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oakland University-William Beaumont School of Medicine, Royal Oak, MI 48309, USA"},{"name":"Corewell Health William Beaumont University Hospital, Royal Oak, MI 48073, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4286-7481","authenticated-orcid":false,"given":"Onur","family":"Turkoglu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oakland University-William Beaumont School of Medicine, Royal Oak, MI 48309, USA"},{"name":"Corewell Health William Beaumont University Hospital, Royal Oak, MI 48073, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1001-0002","authenticated-orcid":false,"given":"Stewart F.","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oakland University-William Beaumont School of Medicine, Royal Oak, MI 48309, USA"},{"name":"Corewell Health William Beaumont University Hospital, Royal Oak, MI 48073, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6617-5634","authenticated-orcid":false,"given":"Uppala","family":"Radhakrishna","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oakland University-William Beaumont School of Medicine, Royal Oak, MI 48309, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1038\/s41467-022-33394-7","article-title":"DNA methylation signatures of Alzheimer\u2019s disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types","volume":"13","author":"Shireby","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1038\/s41598-020-71239-9","article-title":"Plasma cell-free DNA methylation marks for episodic memory impairment: A pilot twin study","volume":"10","author":"Konki","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-220301","article-title":"Circulating Cell-Free Genomic DNA Is Associated with an Increased Risk of Dementia and with Change in Cognitive and Physical Function","volume":"89","author":"Nidadavolu","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.3233\/JAD-179932","article-title":"Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology","volume":"64","author":"Hampel","year":"2018","journal-title":"J. Alzheimer\u2019s Dis. JAD"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13148-019-0672-7","article-title":"DNA methylation signature of human hippocampus in Alzheimer\u2019s disease is linked to neurogenesis","volume":"11","author":"Altuna","year":"2019","journal-title":"Clin. Epigenet."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bahado-Singh, R.O., Radhakrishna, U., Gordevi\u010dius, J., Aydas, B., Yilmaz, A., Jafar, F., Imam, K., Maddens, M., Challapalli, K., and Metpally, R.P. (2022). Artificial Intelligence and Circulating Cell-Free DNA Methylation Profiling: Mechanism and Detection of Alzheimer\u2019s Disease. Cells, 11.","DOI":"10.3390\/cells11111744"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2020.1858856","article-title":"Cytochrome P450 expression and regulation in the brain","volume":"53","author":"Kuban","year":"2021","journal-title":"Drug Metab. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.apha.2022.04.003","article-title":"Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain","volume":"95","author":"Stocco","year":"2022","journal-title":"Adv. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03602532.2018.1439502","article-title":"Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases","volume":"50","year":"2018","journal-title":"Drug Metab. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20120431","DOI":"10.1098\/rstb.2012.0431","article-title":"Human cytochromes P450 in health and disease","volume":"368","author":"Nebert","year":"2013","journal-title":"Philos. Trans. R. Soc. London. Ser. B Biol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., and He, L. (2021). Cytochrome P450 Enzymes and Drug Metabolism in Humans. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312808"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fphys.2020.00598","article-title":"Involvement of Lipids in Alzheimer\u2019s Disease Pathology and Potential Therapies","volume":"11","author":"Chew","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"690372","DOI":"10.3389\/fnagi.2021.690372","article-title":"Cholesterol and Alzheimer\u2019s Disease; From Risk Genes to Pathological Effects","volume":"13","author":"Feringa","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.amjopharm.2011.07.003","article-title":"Cytochrome P450 2D6 phenotyping in an elderly population with dementia and response to galantamine in dementia: A pilot study","volume":"9","author":"Clarke","year":"2011","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13195-021-00893-6","article-title":"Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer\u2019s disease","volume":"13","author":"Borkowski","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1212\/NXG.0000000000000216","article-title":"CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem","volume":"4","author":"Benedet","year":"2018","journal-title":"Neurol. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1533317519848237","article-title":"Effect of CYP2D6 and CYP3A4 Genotypes on the Efficacy of Cholinesterase Inhibitors in Southern Chinese Patients with Alzheimer\u2019s Disease","volume":"34","author":"Ma","year":"2019","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Dement."},{"key":"ref_18","first-page":"P646","article-title":"P2-093: Polymorphism in Cytochrome P450 Gene is Associated with Alzheimer\u2019s Pathology","volume":"12","author":"Benedet","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pharmthera.2013.03.010","article-title":"Epigenetics: A novel therapeutic approach for the treatment of Alzheimer\u2019s disease","volume":"139","author":"Adwan","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ibneur.2022.12.002","article-title":"The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders","volume":"14","author":"Rasmi","year":"2023","journal-title":"IBRO Neurosci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1389200013338513","article-title":"Cytochrome P450 in the brain; a review","volume":"2","author":"Hedlund","year":"2001","journal-title":"Curr. Drug Metab."},{"key":"ref_22","unstructured":"Huang, X. (2020). Alzheimer\u2019s Disease: Drug Discovery, Exon Publications."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00228-022-03363-6","article-title":"Pharmacotherapy of Alzheimer\u2019s disease: An overview of systematic reviews","volume":"78","author":"Majidazar","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_24","first-page":"259","article-title":"DNA methylation and regulation of gene expression: Guardian of our health","volume":"64","author":"Dhar","year":"2021","journal-title":"Nucl. Int. J. Cytol. Allied Top."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41514-021-00064-9","article-title":"Abnormal brain cholesterol homeostasis in Alzheimer\u2019s disease-a targeted metabolomic and transcriptomic study","volume":"7","author":"Varma","year":"2021","journal-title":"NPJ Aging Mech. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbalip.2014.07.020","article-title":"Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism","volume":"1851","author":"Spector","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Akwa, Y. (2020). Steroids and Alzheimer\u2019s Disease: Changes Associated with Pathology and Therapeutic Potential. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134812"},{"key":"ref_28","first-page":"14","article-title":"Sex and Gender Differences in Alzheimer\u2019s Disease Dementia","volume":"35","author":"Mielke","year":"2018","journal-title":"Psychiatr. Times"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yhbeh.2012.04.006","article-title":"Gender, sex steroid hormones, and Alzheimer\u2019s disease","volume":"63","author":"Vest","year":"2013","journal-title":"Horm. Behav."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Cacabelos, R. (2020). Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093059"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"D406","DOI":"10.1051\/ocl\/2018033","article-title":"Dietary arachidonic acid: A Janus face actor in brain and Alzheimer\u2019s disease?","volume":"25","author":"Pinchaud","year":"2018","journal-title":"OCL"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29245\/2572.942X\/2016\/9.1086","article-title":"Arachidonic acid in Alzheimer\u2019s disease","volume":"1","author":"Thomas","year":"2016","journal-title":"J. Neurol. Neuromed."},{"key":"ref_33","unstructured":"Cacabelos, R., Cacabelos, P., and Torrellas, C. (2014). Handbook of Pharmacogenomics and Stratified Medicine, Elsevier."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13148-022-01416-2","article-title":"Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy","volume":"14","author":"Leal","year":"2022","journal-title":"Clin. Epigenet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41586-022-05580-6","article-title":"A DNA methylation atlas of normal human cell types","volume":"613","author":"Loyfer","year":"2023","journal-title":"Nature"},{"key":"ref_36","first-page":"E1826","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Neiman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bahado-Singh, R.O., Vishweswaraiah, S., Aydas, B., Yilmaz, A., Metpally, R.P., Carey, D.J., Crist, R.C., Berrettini, W.H., Wilson, G.D., and Imam, K. (2021). Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer\u2019s disease. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248375"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"639233","DOI":"10.3389\/fcell.2021.639233","article-title":"Cell-Free DNA: Hope and Potential Application in Cancer","volume":"9","author":"Yan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s12253-018-0382-z","article-title":"Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection","volume":"25","author":"Galamb","year":"2019","journal-title":"Pathol. Oncol. Res. POR"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/15384047.2019.1598759","article-title":"Life and death of circulating cell-free DNA","volume":"20","author":"Kustanovich","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/gutjnl-2016-311526","article-title":"Plasma DNA methylation: A potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease","volume":"66","author":"Hardy","year":"2017","journal-title":"Gut"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"701017","DOI":"10.3389\/fnins.2021.701017","article-title":"Epigenetics Is Implicated in the Basis of Gender Incongruence: An Epigenome-Wide Association Analysis","volume":"15","author":"Ramirez","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41596-022-00710-w","article-title":"Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data","volume":"17","author":"Pang","year":"2022","journal-title":"Nat. Protoc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"W127","DOI":"10.1093\/nar\/gks374","article-title":"MetaboAnalyst 2.0\u2014A comprehensive server for metabolomic data analysis","volume":"40","author":"Xia","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression Shrinkage and Selection via the Lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"ref_47","first-page":"280","article-title":"Translational biomarker discovery in clinical metabolomics: An introductory tutorial","volume":"9","author":"Xia","year":"2013","journal-title":"Metab. Off. J. Metab. Soc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/bioinformatics\/btr661","article-title":"Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data","volume":"28","author":"Karnovsky","year":"2012","journal-title":"Bioinformatics"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2876\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:22:02Z","timestamp":1760120522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032876"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032876","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]}}}